Barclays’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.33M | Buy |
|
|||||
|
2025
Q1 | $2.41M | Sell |
|
|||||
|
2024
Q4 | $2.79M | Buy |
|
|||||
|
2024
Q3 | $2.47M | Buy |
|
|||||
|
2024
Q2 | $804K | Sell |
|
|||||
|
2024
Q1 | $953K | Sell |
|
|||||
|
2023
Q4 | $1.41M | Buy |
|
|||||
|
2023
Q3 | $236K | Sell |
|
|||||
|
2023
Q2 | $183K | Sell |
|
|||||
|
2023
Q1 | $120K | Buy |
|
|||||
|
2022
Q4 | $124K | Buy |
|
|||||
|
2022
Q3 | $79K | Sell |
|
|||||
|
2022
Q2 | $205K | Sell |
|
|||||
|
2022
Q1 | $273K | Sell |
|
|||||
|
2021
Q4 | $886K | Buy |
|
|||||
|
2021
Q3 | $354K | Buy |
|
|||||
|
2021
Q2 | $124K | Sell |
|
|||||
|
2021
Q1 | $802K | Buy |
|
|||||
|
2020
Q4 | $485K | Sell |
|
|||||
|
2020
Q3 | $508K | Sell |
|
|||||
|
2020
Q2 | $688K | Buy |
|
|||||
|
2020
Q1 | $431K | Sell |
|
|||||
|
2019
Q4 | $676K | Buy |
|
|||||
|
2019
Q3 | $198K | Sell |
|
|||||
|
2019
Q2 | $1.93M | Buy |
|
|||||
|
2019
Q1 | $823K | Buy |
|
|||||
|
2018
Q4 | $18K | Sell |
|
|||||
|
2018
Q3 | $953K | Sell |
|
|||||
|
2018
Q2 | $6.04M | Buy |
|